Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

RANDOMIZED CONTROLLED TRIALS

A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208)

Kansai Hepato-Biliary Oncology Group

Kobayashi, Shogo MD, PhD*,†,§§§; Nagano, Hiroaki MD, PhD*,***,§§§; Tomokuni, Akira MD, PhD†,§§§; Gotoh, Kunihito MD, PhD*,†,§§§; Sakai, Daisuke MD, PhD‡,§§§; Hatano, Etsuro MD, PhD§,¶,§§§; Seo, Satoru MD, PhD§,§§§; Terajima, Hiroaki MD, PhD||,§§§; Uchida, Yoichiro MD, PhD||,§§§; Ajiki, Tetsuo MD, PhD**,§§§; Satake, Hironaga MD, PhD††,§§§; Kamei, Keiko MD, PhD‡‡,§§§; Tohyama, Taiji MD, PhD§§,§§§; Hirose, Tetsuro MD, PhD¶¶,§§§; Ikai, Iwao MD, PhD||||,§§§; Morita, Satoshi PhD†††,§§§; Ioka, Tatsuya MD‡‡‡,§§§ on behalf of the Kansai Hepato-Biliary Oncology (KHBO) Group

Author Information
doi: 10.1097/SLA.0000000000002865
  • Buy

Abstract

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.